Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
HYDROMORPHONE HYDROCHLORIDE INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 10MG Updated Report 2024-06-10 230030
IRINOTECAN HYDROCHLORIDE INJECTION USP PFIZER CANADA ULC Actual shortage 20MG Updated Report 2024-06-10 227322
DONEPEZIL SANIS HEALTH INC Actual shortage 5MG Updated Report 2024-06-10 228969
REMERON RD ORGANON CANADA INC. Avoided shortage 15MG Updated Report 2024-06-10 227146
PERSANTINE GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE Resolved 5MG Updated Report 2024-06-10 181380
DIPYRIDAMOLE INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 5MG Updated Report 2024-06-10 193649
TRIDURAL PALADIN PHARMA INC. Actual shortage 100MG Updated Report 2024-06-08 229156
5% DEXTROSE INJECTION, USP BAXTER CORPORATION Actual shortage 5G Updated Report 2024-06-08 229851
ACH-FINASTERIDE ACCORD HEALTHCARE INC Actual shortage 5MG Updated Report 2024-06-08 229914
ACH-QUETIAPINE ACCORD HEALTHCARE INC Actual shortage 150MG Updated Report 2024-06-08 229917

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
GLUCONORM 2.0MG NOVO NORDISK CANADA INC To be discontinued 2.0MG Updated Report 2024-06-05 201489
ISENTRESS MERCK CANADA INC To be discontinued 100MG Updated Report 2024-06-04 204160
PRO-DESVENLAFAXINE PRO DOC LIMITEE Discontinued 100MG New Report 2024-06-04 229623
PRO-DESVENLAFAXINE PRO DOC LIMITEE Discontinued 50MG New Report 2024-06-04 229620
SUPREFACT DEPOT 2 MONTHS CHEPLAPHARM ARZNEIMITTEL GMBH To be discontinued 6.3MG New Report 2024-06-03 228169